Discontinuation report CIPRO
Report ID | 96049 |
Drug Identification Number | 02155966 |
Brand name | CIPRO |
Common or Proper name | CIPROFLOXACIN |
Company Name | BAYER INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | CIPROFLOXACIN |
Strength(s) | 500MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100's |
ATC code | J01MA |
ATC description | QUINOLONE ANTIBACTERIALS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2020-04-30 |
Actual discontinuation date | 2020-04-28 |
Remaining supply date | 2020-04-30 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2920 MATHESON BLVD EAST MISSISSAUGA, ONTARIO CANADA L4W 5R6 |
Company contact information | 1-800-265-7382 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v16 | 2020-04-30 | French | Compare |
v15 | 2020-04-30 | English | Compare |
v14 | 2020-04-02 | French | Compare |
v13 | 2020-04-02 | English | Compare |
v12 | 2020-03-04 | French | Compare |
v11 | 2020-03-04 | English | Compare |
v10 | 2020-01-27 | French | Compare |
v9 | 2020-01-27 | English | Compare |
v8 | 2019-12-11 | French | Compare |
v7 | 2019-12-11 | English | Compare |
v6 | 2019-11-20 | French | Compare |
v5 | 2019-11-20 | English | Compare |
v4 | 2019-11-20 | French | Compare |
v3 | 2019-11-20 | English | Compare |
v2 | 2019-10-10 | French | Compare |
v1 | 2019-10-10 | English | Compare |
Showing 1 to 16 of 16